EUVIMEDEUVIMED entdecken
Metaanalyse

WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis

Cai-Xia Liang, Yuan-Kai Shi, Xiao-Hong Han

Chronic Diseases and Translational Medicine · 2018

DOI: 10.1016/j.cdtm.2018.02.004 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Chronic Diseases and Translational Medicine, 2018. Verfasst von Cai-Xia Liang und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission Major Project, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Beijing Municipal Science and Technology Commission Major Project
  • National Natural Science Foundation of China

Zitieren

APA

Liang, C., Shi, Y., & Han, X. (2018). WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis. Chronic Diseases and Translational Medicine. https://doi.org/10.1016/j.cdtm.2018.02.004

Vancouver

Liang C, Shi Y, Han X. WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis. Chronic Diseases and Translational Medicine. 2018. doi:10.1016/j.cdtm.2018.02.004

BibTeX
@article{Liang2018,
  author = {Liang, Cai-Xia and Shi, Yuan-Kai and Han, Xiao-Hong},
  title = {WITHDRAWN: Anti-p53 autoantibody as a diagnostic biomarker for non-small cell lung cancer: A meta-analysis},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2018},
  doi = {10.1016/j.cdtm.2018.02.004}
}
Kostenlos starten →